As of Jul 31
| +0.0117 / +9.13%|
The 1 analysts offering 12-month price forecasts for Boston Therapeutics Inc have a median target of 1.80, with a high estimate of 1.80 and a low estimate of 1.80. The median estimate represents a +1,186.63% increase from the last price of 0.14.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.